ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,981 | -34.7% | 24,915 | +2.3% | 0.00% | 0.0% |
| Q2 2023 | $121,029 | -2.3% | 24,352 | -2.9% | 0.00% | 0.0% |
| Q1 2023 | $123,851 | -19.1% | 25,071 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $153,143 | -39.5% | 24,347 | +4.0% | 0.00% | -66.7% |
| Q3 2022 | $253,000 | -4.5% | 23,414 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $265,000 | +37.3% | 23,212 | +9.6% | 0.00% | +50.0% |
| Q1 2022 | $193,000 | -38.5% | 21,188 | +0.7% | 0.00% | 0.0% |
| Q4 2021 | $314,000 | -42.4% | 21,048 | -0.7% | 0.00% | -50.0% |
| Q3 2021 | $545,000 | -0.5% | 21,205 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $548,000 | -15.6% | 21,028 | +14.4% | 0.00% | -33.3% |
| Q1 2021 | $649,000 | +41.4% | 18,376 | +1.1% | 0.01% | +50.0% |
| Q4 2020 | $459,000 | -28.5% | 18,177 | +6.8% | 0.00% | -33.3% |
| Q3 2020 | $642,000 | +18.2% | 17,016 | +34.1% | 0.01% | -25.0% |
| Q2 2020 | $543,000 | – | 12,687 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |